Progress in Rare Cancers Is ASCO Advance of the Year Progress in Rare Cancers Is ASCO Advance of the Year
Progress in the treatment of several rare types of cancer has been highlighted as clinical cancer advances of the past year.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 4, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Impressive' Activity with BRAF/MEK Inhibitors in Biliary Cancer'Impressive' Activity with BRAF/MEK Inhibitors in Biliary Cancer
Combination therapy with dabrafenib and trametinib produced promising results in patients with advanced BRAF V600E-mutated biliary cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 24, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

High Fiber, Whole Grains Linked to Lower CVD, Diabetes, Cancer Risk High Fiber, Whole Grains Linked to Lower CVD, Diabetes, Cancer Risk
An ambitious review of 40 years of research commissioned by the WHO shows that higher intake of dietary fiber and whole grains is related to a'surprisingly broad'range of diseases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 15, 2019 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

Cabozantinib Now Also FDA Approved for Liver Cancer Cabozantinib Now Also FDA Approved for Liver Cancer
A new indication allows cabozantinib to be used in patients with hepatocellular carcinoma who have previously been treated with sorafenib.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Could Gail Model Allow Personalized Breast Screening? Could Gail Model Allow Personalized Breast Screening?
The Gail model could allow breast cancer screening intervals to be adjusted individually on the basis of the patient's risk for invasive breast cancer, although many hurdles remain, say Australian scientists.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 8, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Remarkably Distressing': 35% of US Population Obese'Remarkably Distressing': 35% of US Population Obese
The state of obesity 2018: Dr Maurie Markman discusses sobering statistics demonstrating this serious public health problem in the United States.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 20, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

UK Multimillionaire Jailed for Peddling Fake Cancer'Cure'UK Multimillionaire Jailed for Peddling Fake Cancer'Cure '
The founder of a British company that sold products containing a plasma-derived protein to thousands of vulnerable patients by claiming it could cure cancer, among other diseases, has been jailed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Oncologist Mom With Baby Bounced From Poster Session Oncologist Mom With Baby Bounced From Poster Session
At a recent oncology meeting, a physician researcher attempted to bring her 6-month-old son with her to a poster session, but they were denied entry.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 5, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

HPV Vaccine Uptake Low Despite Prior Calls to Action HPV Vaccine Uptake Low Despite Prior Calls to Action
More action is needed to increase HPV vaccine uptake in the United States and elsewhere, according to the President's Cancer Report.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 5, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

No De-escalation of Therapy for HPV+ Throat Cancer No De-escalation of Therapy for HPV+ Throat Cancer
De-escalating therapy by using cetuximab with radiotherapy did not improve side effects and, more importantly, had worse survival compared with chemoradiotherapy for patients with good prognosis HPV+ throat cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 26, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Precision RT May Prove Curative in Oligometastatic Cancer Precision RT May Prove Curative in Oligometastatic Cancer
Precision, high-dose radiotherapy targeting isolated metastatic lesions significantly boosts overall and progression-free survival, with good quality of life for patients with oliogometastatic tumors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 19, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

CAR T-Cell Therapy for Pediatric Leukemia Is Cost-effective CAR T-Cell Therapy for Pediatric Leukemia Is Cost-effective
A new analysis shows that, despite its exorbitant price tag, the CAR T-cell therapy tisagenlecleucel for pediatric leukemia appears to be cost-effective.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 9, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' I Wonder if I Betrayed Him': When the Patient Is a Colleague'I Wonder if I Betrayed Him': When the Patient Is a Colleague
David Kerr discusses the loss of a colleague and personal friend whom he treated, and how this experience differed--and did not differ--from his other patient care experiences.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 7, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Colorectal Cancer Screening Should Begin at Age 45: Coalition Colorectal Cancer Screening Should Begin at Age 45: Coalition
A coalition of healthcare organizations is urging the United States Preventive Services Task Force to update its recommendation on colorectal cancer screening and lower the starting age from 50 to 45 years.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 30, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First CAR T Cell Approved in Europe First CAR T Cell Approved in Europe
The European Commission has approved the first CAR T-cell product, tisagenlecleucel, for the treatment of certain leukemias and lymphomas.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 27, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lenvatinib for Liver Cancer Approved in Europe Lenvatinib for Liver Cancer Approved in Europe
The European Commission granted marketing authorization to lenvatinib as first-line treatment in advanced or unresectable hepatocellular carcinoma.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 23, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

KEYNOTE-224: Pembrolizumab Active, Tolerable in HCC KEYNOTE-224: Pembrolizumab Active, Tolerable in HCC
Dr David Kerr discusses the safety and efficacy of pembrolizumab in patients with pretreated, advanced HCC.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 16, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

' Compelling' Regimen for Resectable Advanced-Stage Melanoma'Compelling' Regimen for Resectable Advanced-Stage Melanoma
Dr Weber reviews a new trial comparing neoadjuvant and adjuvant dual MEK/BRAF inhibition to standard of care in advanced resectable melanoma.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 16, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

New Biomarkers for Immunotherapy: The Microbiome and Beyond New Biomarkers for Immunotherapy: The Microbiome and Beyond
Jeffrey Weber and April Salama discuss the pitfalls of current biomarkers to pick cancer treatments, the influence of the microbiome, and the search for peripheral blood markers.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 28, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Clinical Pathways: Many Potential Benefits but'More Work to Do'Clinical Pathways: Many Potential Benefits but'More Work to Do '
Drs Miller and Zon discuss the current challenges associated with clinical pathways in oncology.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 20, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Survival Longer With Obinutuzumab Compared to Rituximab in CLL Survival Longer With Obinutuzumab Compared to Rituximab in CLL
New longer-term results with overall survival data confirm the superiority of the newer agent over the earlier-generation anti-CD20 drug rituximab for previously untreated chronic lymphocytic leukemia (CLL).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 20, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Higher Vitamin D Levels Tied to Lower Colorectal Cancer Risk Higher Vitamin D Levels Tied to Lower Colorectal Cancer Risk
Higher vitamin D levels in the blood may protect against colorectal cancer, especially in women, but optimal concentrations may be higher than levels currently recommended for bone health.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 15, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

TAILORx Provides'Clear Answer' for ER+ Breast Cancer TAILORx Provides'Clear Answer' for ER+ Breast Cancer
Lead investigator Joseph Sparano discusses the pivotal TAILORx trial presented at ASCO 2018. It's a'great day for patients,'says Kathy Miller.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 13, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Top 5 Lung Cancer Presentations at ASCO 2018 Top 5 Lung Cancer Presentations at ASCO 2018
Thoracic oncologist Dr Jack West discusses the five most important and clinically relevant abstracts to be presented at the upcoming ASCO 2018 annual meeting.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 30, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Article Source Type: news

Dealing With Data Overload in Oncology Dealing With Data Overload in Oncology
From pharmaceutical press releases to highly motivated online patient groups, oncologists are on the receiving end of a firehose of information. Here are some solutions. (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 30, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

More Lung Cancer in Young Women Than Men in US More Lung Cancer in Young Women Than Men in US
The incidence of lung cancer in young women has now surpassed that of their male counterparts, and the unique smoking behaviors of men and women don't explain why.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 25, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Richter's Esmya Drug May Have Contributed to Liver Damage Cases-EMA Richter's Esmya Drug May Have Contributed to Liver Damage Cases-EMA
Hungarian drugmaker Richter's drug Esmya (ulipristal acetate) used to treat benign tumors of the womb may have contributed to some cases of serious liver damage, European health regulators said on Friday after a months-long review.Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 21, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Advanced Thyroid Cancer Gene Study Reveals Therapy Possibilities Advanced Thyroid Cancer Gene Study Reveals Therapy Possibilities
In the largest study of advanced thyroid cancer genetics to date, researchers have found clues to help identify potential candidates for immunotherapy and lenvatinib, and novel mechanisms of progression.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2018 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

AstraZeneca Wins U.S. Approval for First-line Use of Lung Cancer Drug AstraZeneca Wins U.S. Approval for First-line Use of Lung Cancer Drug
U.S. regulators have expanded use of AstraZeneca's lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic mutation, the company said on Wednesday.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Is IO Monotherapy the New Standard of Care in Advanced NSCLC? Is IO Monotherapy the New Standard of Care in Advanced NSCLC?
Merck has released provocative but limited findings from the KEYNOTE-042 trial that indicate better outcomes for first-line pembrolizumab vs standard chemotherapy in advanced non-small cell lung cancer (NSCLC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

More High-Risk Prostate Cancer Now in the US Than Before More High-Risk Prostate Cancer Now in the US Than Before
More men are presenting with higher-grade, more invasive prostate cancer in the wake of 2012 recommendations not to use the prostatic-specific antigen test for routine screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 27, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Insurance Exec to Oncologists: Take Financial Toxicity Vow Insurance Exec to Oncologists: Take Financial Toxicity Vow
The runaway cost of cancer care could be partly addressed by oncologists'appreciating financial toxicity as much as actual treatment toxicity, said a presenter at the National Comprehensive Cancer Network annual meetingMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 27, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

H pylori Eradication Benefits Patients With Early Gastric Cancer H pylori Eradication Benefits Patients With Early Gastric Cancer
Patients with early gastric cancer treated for Helicobacter pylori had a lower incidence of metachronous gastric cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Medicare Will Cover Advanced Genetics Testing in Cancer Patients Medicare Will Cover Advanced Genetics Testing in Cancer Patients
CMS has finalized its coverage for next-generation sequencing (NGS) testing, and patients with cancer who meet the criteria will be reimbursedMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Genetic Mutations and Prostate Cancer: Screening Recommendations Genetic Mutations and Prostate Cancer: Screening Recommendations
In light of recently published data, Dr David Graham suggests potential approaches to prostate cancer screening that incorporate genetic test results.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 14, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

' Unethical': Cancer Care Bills Inflated 5 to 15 Times'Unethical': Cancer Care Bills Inflated 5 to 15 Times
Some medical centers providing cancer care are charging 5 to 15 times more than the Medicare allowable amount; this looks like price gouging and is unethical, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 27, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Europe Says No to Neratinib for Breast Cancer Europe Says No to Neratinib for Breast Cancer
The European committee recommended against approval of neratinib (Nerlynx) for breast cancer, even though the drug has been approved in the United States.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Overlooked Biomarker May Predict Cancer Immunotherapy Response Overlooked Biomarker May Predict Cancer Immunotherapy Response
Dr David Kerr on data showing that tumors with extensive aneuploidy may not benefit as much from immune checkpoint blockade.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 15, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

More Than Half of UK Docs Support Assisted Dying More Than Half of UK Docs Support Assisted Dying
The British Medical Association has long been opposed to assisted dying, but a recent poll found that 55% of physicians would support its becoming legal in defined circumstances.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 8, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Pattern in Gastric Cancer: One Type Increasing in US New Pattern in Gastric Cancer: One Type Increasing in US
One type of gastric cancer is on the increase, especially among individuals younger than 50 years. Women are more at risk than men.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 31, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Survival After Breast Cancer'Unaffected by BRCA Status'Survival After Breast Cancer'Unaffected by BRCA Status '
The likelihood that young women survive primary breast cancer is unaffected by whether or not they carry mutations in the BRCA gene, say UK researchers in a 10-year follow-up study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Rhabdomyosarcoma Not a'Muscle' Cancer After All Rhabdomyosarcoma Not a'Muscle' Cancer After All
Rhabdomyosarcoma does not arise from immature muscle cells as previously believed but from endothelial progenitor cells, and this could have implications for new therapies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 15, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Expands Use of Denosumab to Myeloma Patients FDA Expands Use of Denosumab to Myeloma Patients
Amgen Inc said on Friday that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 8, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Hormonal Therapy in Advanced Endometrial Cancer Hormonal Therapy in Advanced Endometrial Cancer
This meta-analysis may finally clarify which patients are most likely to respond to hormonal therapy.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 15, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

New Potential Drug Therapy for AI-Associated Arthralgia New Potential Drug Therapy for AI-Associated Arthralgia
The anti-depressant duloxetine effectively reduced musculoskeletal symptoms early in the course of treatment with aromatase inhibitors for early-stage breast cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 15, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Viewpoint Source Type: news

Second Cancers Common in Survivors, Especially Older Adults Second Cancers Common in Survivors, Especially Older Adults
Second cancers affect about 25% of survivors 65 years and older, but patients with cancer who have had a prior malignancy are regularly excluded from clinical trials.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 22, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Prostate Cancer Care Is'Changing Rapidly': ESMO 2017 Prostate Cancer Care Is'Changing Rapidly': ESMO 2017
Exciting research presented at ESMO 2017 will likely affect clinical practice in metastatic prostate cancer, says Dr Johann de Bono.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 17, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

FDA: Don't Remove Uterine Fibroids With Ultrasonic Aspirators FDA: Don't Remove Uterine Fibroids With Ultrasonic Aspirators
The agency's nonbinding recommendation points to the same risk posed by power morcellators -- the inadvertent dispersion of occult cancer. ACOG disagrees with the new guidance.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 31, 2017 Category: Cancer & Oncology Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news

' Important' Progress in Gynecologic Cancers: ESMO 2017'Important' Progress in Gynecologic Cancers: ESMO 2017
Dr Banerjee discusses advances in ovarian and cervical cancers presented at ESMO 2017.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 30, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Two Things That Go Together: Yoga and Advanced Lung Cancer Two Things That Go Together: Yoga and Advanced Lung Cancer
Participating in a yoga program while undergoing radiation therapy improved physical functioning and mental in NSCLC patients, and improved vitality in caregivers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 23, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news